IP Library Granted Patent US 8,940,916
Granted Patent B2
US 8,940,916 · App. 13/828,195 · Granted Jan 27, 2015

Crystallization of (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D3

Inventors: Hector F. DeLuca (Deerfield, WI); Agnieszka Flores (Madison, WI); James B. Thoden (Madison, WI); Hazel M. Holden (Fitchburg, WI)
Assignee: Wisconsin Alumni Research Foundation
C07C401/00C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,940,916
App. No.
13/828,195
Granted
Jan 27, 2015
Kind
B2
Abstract

Disclosed are methods of purifying the compound (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D 3 to obtain the compound in crystalline form. The methods typically include the steps of dissolving a product containing the compound in a solvent comprising hexane and 2-propanol, cooling the solvent and dissolved product below ambient temperature for a sufficient amount of time to form a precipitate of crystals, and recovering the crystals.

Claims (15)

1. A compound having the formula:

in crystalline form, and named (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D 3 .

2. A crystalline form of (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D 3 having molecular packing arrangement defined by space group C2 and unit cell dimensions a=23.84Å b=6.27Å c=20.71 Å α=90°, β=126.52° and γ=90°.

3. A three dimensional structure for (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D 3 as defined by the molecular packing arrangement set forth in claim 2 .

4. A method of purifying (20R)-2-methylene-19-nor-24-difluoro-1α25-dihydroxyvitamin D 3 , comprising the steps of:

(a) preparing a solvent comprising hexane;

(b) adding a product containing (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D 3 to he purified to said hexane to form a suspension of the product in the hexane;

(c) adding 2-propanol dropwise to the suspension to form a mixture of the product in the hexane and 2-propanol;

(d) heating the mixture to dissolve the product containing (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D 3 to be purified in said mixture;

(e) cooling said mixture and dissolved product below ambient temperature for a sufficient amount of time to form a precipitate of (2W)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D 3 crystals; and

(f) separating the (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D 3 crystals from the solvent.

5. The method of claim 4 including the further step of allowing said mixture and dissolved product to cool to ambient temperature prior to cooling below ambient temperature.

6. The method of claim 4 wherein the step of separating comprises filtering the mixture and precipitate to obtain the crystals.

7. The method of claim 4 including a further step (g) comprising repeating steps (a) through (f) using the recovered crystals from step (f) as the product of step (b).

8. The method of claim 4 wherein said mixture comprises about 15% 2-propanol and about 85% hexane, by volume.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 17, 2013
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030232/0066 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2013
From: DELUCA, HECTOR; FLORES, AGNIESZKA; THODEN, JAMES; HOLDEN, HAZEL
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 030051/0970 →
Continuity (2)
Provisional Application 61652959 · May 30, 2012
Related Publication 20130324750A1 · Dec 5, 2013